SCHEMBL4693029

SCHEMBL4693029

CCOC(=N)c1cc(COC)cc(C(=O)OCC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.51
CA12 O43570 3/20 0.51
CA1 P00915 3/20 0.51
CA7 P43166 3/20 0.51
CA9 Q16790 3/20 0.51
CA14 Q9ULX7 3/20 0.51
KDM4E B2RXH2 1/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
TSHR P16473 2/20 0.42
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.41
CYP4F2 P78329 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4652562 0.84 CYP2C9 (0.55) CA2CA12CA1CA7CA9
Hydrochloric Acid SCHEMBL4695058 0.80 DGAT1 (0.36) CA2CA12CA1CA7CA9
SCHEMBL4693441 0.77 CA12 (0.49) CA2CA12CA1CA7CA9
SCHEMBL3853793 0.76 CA12 (0.45) CA2CA12CA1CA7CA9
SCHEMBL10290650 0.76 CA12 (0.64) CA2CA12CA1CA7CA9
SCHEMBL1664013 0.76 CA12 (0.75) CA2CA12CA1CA7CA9
SCHEMBL23635693 0.75 CYP4F2 (0.64) CA2CA12CA1CA7CA9
SCHEMBL4652561 0.75 CA12 (0.57) CA2CA12CA1CA7CA9
SCHEMBL10287538 0.74 CA12 (0.67) CA2CA12CA1CA7CA9
SCHEMBL16048292 0.73 CA1 (0.66) CA2CA12CA1CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1463501-B1 CIS-IMIDAZOLINES AS MDM2 INHIBITORS HOFFMANN LA ROCHE (CH) 2008-06-11 EP disclosed
EP-1463501-A1 CIS-IMIDAZOLINES AS MDM2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2004-10-06 EP disclosed
US-6617346-B1 Inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activity HOFFMANN-LA ROCHE INC. 2003-09-09 US disclosed
WO-2003051360-A1 CIS-IMIDAZOLINES AS MDM2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-06-26 WO disclosed